- Home
- ALVO vs BBUC Comparison
ALVO vs BBUC Comparison
Compare ALVO & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- BBUC
- Stock Information
- Founded
- ALVO 2013
- BBUC 2022
- Country
- ALVO Luxembourg
- BBUC United States
- Employees
- ALVO N/A
- BBUC N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- BBUC
- Sector
- ALVO Health Care
- BBUC
- Exchange
- ALVO Nasdaq
- BBUC Nasdaq
- Market Cap
- ALVO 2.5B
- BBUC 2.3B
- IPO Year
- ALVO N/A
- BBUC N/A
- Fundamental
- Price
- ALVO $8.33
- BBUC $33.83
- Analyst Decision
- ALVO
- BBUC
- Analyst Count
- ALVO 0
- BBUC 0
- Target Price
- ALVO N/A
- BBUC N/A
- AVG Volume (30 Days)
- ALVO 486.2K
- BBUC 87.9K
- Earning Date
- ALVO 08-13-2025
- BBUC 11-01-2025
- Dividend Yield
- ALVO N/A
- BBUC 0.74%
- EPS Growth
- ALVO N/A
- BBUC N/A
- EPS
- ALVO 0.22
- BBUC N/A
- Revenue
- ALVO $562,478,000.00
- BBUC $8,240,000,000.00
- Revenue This Year
- ALVO $33.32
- BBUC N/A
- Revenue Next Year
- ALVO $46.16
- BBUC N/A
- P/E Ratio
- ALVO $37.86
- BBUC N/A
- Revenue Growth
- ALVO 82.19
- BBUC 6.96
- 52 Week Low
- ALVO $7.35
- BBUC $20.23
- 52 Week High
- ALVO $13.70
- BBUC $35.19
- Technical
- Relative Strength Index (RSI)
- ALVO 48.09
- BBUC 58.76
- Support Level
- ALVO $7.85
- BBUC $32.45
- Resistance Level
- ALVO $8.12
- BBUC $35.19
- Average True Range (ATR)
- ALVO 0.27
- BBUC 1.00
- MACD
- ALVO 0.01
- BBUC -0.03
- Stochastic Oscillator
- ALVO 39.47
- BBUC 67.87
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.